+143.3%
MRNA vs SMTC
+102.5%
+40.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | SMTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.8% | -4.2% | -3.1% |
| 7D | -10.1% | +22.5% | -32.6% | -4.0% |
| 30D | +126.7% | +24.9% | +101.8% | +145.2% |
| 3M | +184.1% | +4.1% | +180.0% | +200.9% |
| 6M | +143.3% | +92.6% | +50.7% | +134.3% |
| All | +143.3% | +102.5% | +40.8% | +134.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SMTC.
Daily Out/Under-Performance
Portfolio return minus SMTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SMTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded SMTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling